Page last updated: 2024-08-22

sodium selenite and Cancer of Ovary

sodium selenite has been researched along with Cancer of Ovary in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Cho, H; Choi, JA; Kim, JH; Lee, EH	1
Bindoli, A; Björnstedt, M; Fernandes, AP; Folda, A; Gandin, V; Marzano, C; Rigobello, MP; Rundlöf, AK	1
Dziaman, T; Gackowski, D; Guz, J; Huzarski, T; Lubinski, J; Olinski, R; Roszkowski, K; Rozalski, R; Siomek, A; Szpila, A; Wasowicz, W	1
Bindoli, A; Björnstedt, M; Citta, A; Fernandes, AP; Folda, A; Gandin, V; Marzano, C; Rigobello, MP; Rundlöf, AK; Scutari, G	1
Caffrey, PB; Frenkel, GD	2
Caffrey, PB; Frenkel, GD; Zhu, M	1

Trials

1 trial(s) available for sodium selenite and Cancer of Ovary

Article	Year
Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:11 Topics: 8-Hydroxy-2'-Deoxyguanosine; Adnexal Diseases; BRCA1 Protein; Breast Neoplasms; Case-Control Studies; Chromatography, High Pressure Liquid; Deoxyguanosine; Dietary Supplements; DNA Damage; Double-Blind Method; Female; Humans; Leukocytes; Mutation; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Placebos; Prognosis; Sodium Selenite; Uric Acid; Vitamins	2009

Article

Year

Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:11

Topics: 8-Hydroxy-2'-Deoxyguanosine; Adnexal Diseases; BRCA1 Protein; Breast Neoplasms; Case-Control Studies; Chromatography, High Pressure Liquid; Deoxyguanosine; Dietary Supplements; DNA Damage; Double-Blind Method; Female; Humans; Leukocytes; Mutation; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Placebos; Prognosis; Sodium Selenite; Uric Acid; Vitamins

2009

Other Studies

6 other study(ies) available for sodium selenite and Cancer of Ovary

Article	Year
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International journal of molecular sciences, 2023, Jan-18, Volume: 24, Issue:3 Topics: Animals; Cell Death; Female; Glutathione Peroxidase; Humans; Mice; Ovarian Neoplasms; Selenium; Selenoproteins; Sodium Selenite	2023
Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift. Free radical biology & medicine, 2009, Sep-15, Volume: 47, Issue:6 Topics: Adenocarcinoma; Auranofin; Cell Death; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Ovarian Neoplasms; Sodium Selenite; Tellurium; Thioredoxin-Disulfide Reductase	2009
Interaction of selenite and tellurite with thiol-dependent redox enzymes: Kinetics and mitochondrial implications. Free radical biology & medicine, 2011, Jun-01, Volume: 50, Issue:11 Topics: Animals; Auranofin; Cell Line, Tumor; Cell Membrane Permeability; Female; Glutathione Reductase; Humans; Kinetics; Membrane Potential, Mitochondrial; Mitochondria, Liver; Ovarian Neoplasms; Oxidation-Reduction; Pyridines; Rats; Sodium Selenite; Substrate Specificity; Sulfhydryl Compounds; Tellurium; Thioredoxin-Disulfide Reductase; Yeasts	2011
The development of drug resistance by tumor cells in vitro is accompanied by the development of sensitivity to selenite. Cancer letters, 1994, Jun-15, Volume: 81, Issue:1 Topics: Cell Division; Drug Resistance; Female; Glutathione; Humans; Melphalan; Organoselenium Compounds; Ovarian Neoplasms; Sodium Selenite; Tumor Cells, Cultured	1994
Sensitivity of melphalan-resistant tumors to selenite in vivo. Cancer letters, 1997, Dec-23, Volume: 121, Issue:2 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Alkylating; Drug Resistance, Neoplasm; Female; Humans; Melphalan; Mice; Mice, Nude; Ovarian Neoplasms; Sodium Selenite; Tumor Cells, Cultured	1997
Prevention of the development of melphalan resistance in vitro by selenite. Biological trace element research, 1998, Volume: 65, Issue:3 Topics: Antineoplastic Agents, Alkylating; Blotting, Northern; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Melphalan; Ovarian Neoplasms; RNA, Messenger; Sodium Selenite; Tumor Cells, Cultured	1998